Form 8-K - Current report:
SEC Accession No. 0001178913-15-002116
Filing Date
2015-06-25
Accepted
2015-06-25 15:24:13
Documents
7
Period of Report
2015-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1516991.htm 8-K 31757
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 83184
3 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 101154
4 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 14015
5 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 227663
6 logo.jpg GRAPHIC 9929
7 logo2.jpg GRAPHIC 7402
  Complete submission text file 0001178913-15-002116.txt   483252
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 15951711
SIC: 2836 Biological Products, (No Diagnostic Substances)